Paige has been developing algorithms that can detect indiscernible-to-the-eye differences in hematoxylin and eosin-stained (H&E) biopsy slides, aiding doctors in the diagnosis of cancer.
The company has had a frantic past four years. Launches and approvals both in the US and European markets – where it has obtained eight CE marks – have helped...